# Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers

> **NCT02196662** · PHASE1 · COMPLETED · sponsor: **Holy Stone Healthcare Co., Ltd** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** IBD98-M:
- **DRUG:** IBD98-M without HA
- **DRUG:** Delzicol

## Key facts

- **NCT ID:** NCT02196662
- **Lead sponsor:** Holy Stone Healthcare Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196662, "Pharmacokinetics of IBD98-M 400mg-57.5/Day in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02196662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*